Clinical trial
Adjuvant Therapy for Severe COPD Patients in the Stable Phase by an Oxyhydrogen Generator With Nebulizer: A Multi-centric, Randomized, Parallel-control and Double-blinded Clinic Study
NCT02850185 is registered in ClinicalTrials.gov with Shanghai Asclepius Meditec Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Adjuvant Therapy for Severe COPD Patients in the Stable Phase by an Oxyhydrogen Generator With Nebulizer: A Multi-centric, Randomized, Parallel-control and Double-blinded Clinic Study
- Lead sponsor
- Shanghai Asclepius Meditec Inc.
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- July 15, 2016
- Completion date
- December 20, 2020
- Enrollment
- 170 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
copd